Peroxiredoxin 3 inhibitors and methods of use for treating cancer
US-2026069580-A1 · Mar 12, 2026 · US
with the first amino acid being neutral
with the first amino acid being neutral · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K5/06008 |
| Official title | {with the first amino acid being neutral} |
| Display label | with the first amino acid being neutral |
| Total patents | 28 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Aromatic-cationic peptides and uses of same
US-2025051389-A1 · Feb 13, 2025 · US
Dipeptide analogs as TGF-beta inhibitors
US-11046729-B2 · Jun 29, 2021 · US
Aromatic-cationic peptides and uses of same
US-2021130402-A1 · May 6, 2021 · US
Prodrug of an ice inhibitor
US-2020048306-A1 · Feb 13, 2020 · US
Dipeptide analogs as tgf-beta inhibitors
US-2019127420-A1 · May 2, 2019 · US
Cationic lipid cordiarimide hybrid compounds and a process for preparation thereof
US-10266564-B2 · Apr 23, 2019 · US
Aromatic-cationic peptides and uses of same
US-2019106458-A1 · Apr 11, 2019 · US
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
US-2019062748-A1 · Feb 28, 2019 · US
Mitotic kinesin inhibitors and methods of use thereof
US-2018334441-A1 · Nov 22, 2018 · US
Prodrug of an ice inhibitor
US-2018327449-A1 · Nov 15, 2018 · US
Mitotic kinesin inhibitors and methods of use thereof
US-10017482-B2 · Jul 10, 2018 · US
Prodrug of an ICE inhibitor
US-9994613-B2 · Jun 12, 2018 · US
Prodrugs for selective anticancer therapy
US-9872919-B2 · Jan 23, 2018 · US
Cationic lipid cordiarimide hybrid compounds and a process for preparation thereof
US-2017137462-A1 · May 18, 2017 · US
Mitotic kinesin inhibitors and methods of use thereof
US-2017066733-A1 · Mar 9, 2017 · US
Prodrug of an ice inhibitor
US-2017022249-A1 · Jan 26, 2017 · US
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
US-2017022497-A1 · Jan 26, 2017 · US
Aromatic-cationic peptides and uses of same
US-2016376309-A1 · Dec 29, 2016 · US
Mitotic kinesin inhibitors and methods of use thereof
US-9499503-B2 · Nov 22, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K5/06008?
- CPC C07K5/06008 is the Cooperative Patent Classification code for “with the first amino acid being neutral.”
- How many patents are filed under CPC C07K5/06008 (with the first amino acid being neutral)?
- Our database includes 28 publications tagged with this CPC code.
- Is patent activity under CPC C07K5/06008 growing?
- Publication counts under this code: 2 in 2021 vs 1 in 2025 (latest complete years).